Search Results - "van Mierlo, Minke M.F."

Temporal Variation in Staphylococcus aureus Protein A Genotypes from Nose and Skin in Atopic Dermatitis Patients by van Mierlo, Minke M F, Pasmans, Suzanne G M A, Totté, Joan E E, de Wit, Jill, Herpers, Bjorn L, Vos, Margreet C, Klaassen, Corné H W, Pardo, Luba M

“…Staphylococcus aureus colonization is associated with disease severity in patients with atopic dermatitis (AD). To investigate temporal variation in S. aureus…”
Get more information

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series by Ragamin, Aviël, Nouwen, Anouk E M, Dalm, Virgil A S H, van Mierlo, Minke M F, Lincke, Carsten R, Pasmans, Suzanne G M A

“…Netherton syndrome (NS) is a rare potential life-threatening disorder that causes severe defects to the skin barrier. No effective treatment options are…”
Get more information

Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: A randomized controlled trial by de Wit, Jill, Totté, Joan E.E., van Mierlo, Minke M.F., van Veldhuizen, Joyce, van Doorn, Martijn B.A., Schuren, Frank H.J., Willemsen, Sten P., Pardo, Luba M., Pasmans, Suzanne G.M.A.

“…To the Editor: Staphylococcus aureus density is increased in many patients with atopic dermatitis (AD) and is thought to contribute to disease pathogenesis,…”
Get full text

Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial) by Ragamin, Aviël, Schappin, Renske, de Graaf, Marlies, Tupker, Ron A, Fieten, Karin B, van Mierlo, Minke M F, Bronner, Madelon B, Romeijn, Geertruida L E, Sloot, Manon M, Boesjes, Celeste M, van der Rijst, Lisa P, Arents, Bernd W M, Rustemeyer, Thomas, Schuttelaar, Marie L A, Pasmans, Suzanne G M A

“…Increased Staphylococcus aureus (SA) colonization is considered an important factor in the pathogenesis of atopic dermatitis (AD). Antibacterial therapeutic…”
Get full text

Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi‐ethnic paediatric atopic dermatitis cohort by Mierlo, Minke M. F., Caspers, Peter J., Jansen, Marieke S., Puppels, Gerwin J., Nouwen, Anouk E. M., Bronner, Madelon B., Pardo, Luba M., Geel, Michel, Pasmans, Suzanne G. M. A.

Get full text

The influence of treatment in alpine and moderate maritime climate on the composition of the skin microbiome in patients with difficult to treat atopic dermatitis by Mierlo, Minke M.F., Totté, Joan E.E., Fieten, Karin B., den Broek, Tim J., Schuren, Frank H.J., Pardo, Luba M., Pasmans, Suzanne G.M.A.

“…Background The skin microbiome, characterized by an overgrowth of Staphylococcus aureus, plays an important role in the pathogenesis of atopic dermatitis (AD)…”
Get full text

Increased Th22 cell numbers in a general pediatric population with filaggrin haploinsufficiency: The Generation R Study by Looman, Kirsten I. M., Mierlo, Minke M. F., Zelm, Menno C., Hu, Chen, Duijts, Liesbeth, Jongste, Johan C., Nijsten, Tamar, Pardo, Luba M., Kiefte‐de Jong, Jessica C., Moll, Henriëtte A., Pasmans, Suzanne G. M. A., Riggioni, Carmen

“…Background Mutations in the filaggrin gene (FLG) affect epidermal barrier function and increase the risk of atopic dermatitis (AD). We hypothesized that FLG…”
Get full text

The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial): study protocol for a pragmatic randomized controlled trial by Ragamin, Aviël, Fieten, Karin B, Tupker, Ron A, de Wit, Jill, van Mierlo, Minke M F, Jansen, Marieke S, Bronner, Madelon B, Schappin, Renske, Schuren, Frank H J, Romeijn, Margreet L E, Arents, Bernd W M, Polinder, Suzanne, de Graaf, Marlies, Rustemeyer, Thomas, Schuttelaar, Marie L A, Pasmans, Suzanne G M A

“…Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10 to 20% of children and between 2 and 15% of the adults in Western Europe. Since…”
Get full text